Capricor Therapeutics Inc (CAPR)

NASDAQ HEALTHCARE

$28.38 +1.54% RSI 51 Neutral Add Alert

Moving Averages

SMA 200

$20.96

Price above

Company Profile

Capricor Therapeutics, Inc., a biotechnology company, focuses on the development of transformative cell- and exosome-based therapies for the treatment and prevention of a broad spectrum of diseases. The company is headquartered in Beverly Hills, California.

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Market Cap

$1.49B

P/E Ratio

None

EPS

$-2.32

Beta

0.368